Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197

Tumor angiogenesis: therapeutic implications

Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781

The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471

Stimuli-responsive nanocarriers for drug delivery

Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289

Multidrug resistance in cancer: role of ATP–dependent transporters

Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536

Recent advances with liposomes as pharmaceutical carriers

Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151

Doxil® — The first FDA-approved nano-drug: Lessons learned

Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792

ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis

D'Autréaux, B., & Toledano, M. B. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2256 · Cited by 3,642

Matrix metalloproteinases and their inhibitors in connective tissue remodeling

Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282

Modes of resistance to anti-angiogenic therapy

Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953

Drug penetration in solid tumours

Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805

Transplacental Carcinogenesis by Stilbestrol

Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640

Applications of hybrid organic–inorganic nanocomposites

Sanchez, C., Julián, B., Belleville, P., & Popall, M. (2005) · Journal of Materials Chemistry · doi:10.1039/b509097k · Cited by 2,636

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586

Molecular regulation of vessel maturation

Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222

Transmembrane crosstalk between the extracellular matrix and the cytoskeleton

Geiger, B., Bershadsky, A., Pankov, R., & Yamada, K. M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099066 · Cited by 2,209

G 1 Events and Regulation of Cell Proliferation

Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182

A review of stimuli-responsive nanocarriers for drug and gene delivery

Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155

Drug Resistance and the Solid Tumor Microenvironment

Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116

Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications

Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901

Exploiting the enhanced permeability and retention effect for tumor targeting

Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846

A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy

Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,801

Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery

Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663

New developments in liposomal drug delivery

Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600

Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia

Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589

Interfering with pH regulation in tumours as a therapeutic strategy

Neri, D., & Supuran, C. T. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3554 · Cited by 1,547

Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485

Functionalized mesoporous silica materials for controlled drug delivery

Yang, P., Gai, S., & Lin, J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15308d · Cited by 1,399

Transport of molecules in the tumor interstitium: a review.

Jain, R. K. (1987) · PubMed · Cited by 1,378

Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery

Cheng, R., Meng, F., Deng, C., Klok, H.-A., & Zhong, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.084 · Cited by 1,354

Gold nanoparticles: preparation, properties, and applications in bionanotechnology

Yeh, Y.-C., Creran, B., & Rotello, V. M. (2012) · Nanoscale · doi:10.1039/c1nr11188d · Cited by 1,346

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324

To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288

Tumor targeting via EPR: Strategies to enhance patient responses

Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262

Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers

Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248

Challenges and strategies in anti-cancer nanomedicine development: An industry perspective

Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214

Tailor-Made Dual pH-Sensitive Polymer–Doxorubicin Nanoparticles for Efficient Anticancer Drug Delivery

Du, J.-Z., Du, X.-J., Mao, C.-Q., & Wang, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207150n · Cited by 1,172

Molecular imaging in drug development

Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., & Gambhir, S. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2290 · Cited by 1,171

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation

Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170

Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,136

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

Chauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., & Jain, R. K. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.45 · Cited by 1,101

Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,075

The Smart Drug Delivery System and Its Clinical Potential

Liu, D., Yang, F., Xiong, F., & Gu, N. (2016) · Theranostics · doi:10.7150/thno.14858 · Cited by 1,066

Cell Proliferation in Carcinogenesis

Cohen, S. M., & Ellwein, L. B. (1990) · Science · doi:10.1126/science.2204108 · Cited by 1,050

Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs

Jabłońska-Trypuć, A., Matejczyk, M., & Rosochacki, S. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1161620 · Cited by 1,042

Using exosomes, naturally-equipped nanocarriers, for drug delivery

Batrakova, E. V., & Kim, M. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.030 · Cited by 1,041

Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels

Chauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3516 · Cited by 1,031

Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery

Vivero‐Escoto, J. L., Slowing, I. I., Trewyn, B. G., & Lin, V. S. ‐. (2010) · Small · doi:10.1002/smll.200901789 · Cited by 998

Design of Liposomes for Enhanced Local Release of Drugs by Hyperthermia

Yatvin, M. B., Weinstein, J. N., Dennis, W. H., & Blumenthal, R. (1978) · Science · doi:10.1126/science.364652 · Cited by 956

Oxidation-responsive polymeric vesicles

Napoli, A., Valentini, M., Tirelli, N., Müller, M., & Hubbell, J. A. (2004) · Nature Materials · doi:10.1038/nmat1081 · Cited by 889

High-Efficiency Intracellular Magnetic Labeling with Novel Superparamagnetic-Tat Peptide Conjugates

Josephson, L., Tung, C.-H., Moore, A., & Weissleder, R. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980125h · Cited by 882

Cancer nanomedicine: A review of recent success in drug delivery

Tran, S., DeGiovanni, P., Piel, B., & Rai, P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0175-0 · Cited by 879

Conducting‐Polymer Nanotubes for Controlled Drug Release

Abidian, M. R., Kim, D. ‐., & Martin, D. C. (2006) · Advanced Materials · doi:10.1002/adma.200501726 · Cited by 869

Solid stress inhibits the growth of multicellular tumor spheroids

Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J., & Jain, R. K. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-778 · Cited by 859

EPR: Evidence and fallacy

Nichols, J. W., & Bae, Y. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.057 · Cited by 834

Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells

Wang, F., Wang, Y.-C., Dou, S., Xiong, M.-H., Sun, T.-M., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn200007z · Cited by 813

C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration

Teesalu, T., Sugahara, K. N., Kotamraju, V. R., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908201106 · Cited by 812

The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism

Lu, J., Tan, M., & Cai, Q. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.04.001 · Cited by 795

Protein nanoparticles as drug carriers in clinical medicine

Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779

Causes and consequences of tumour acidity and implications for treatment

Stubbs, M., McSheehy, P. M. J., Griffiths, J. R., & Bashford, C. L. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01615-9 · Cited by 778

A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals

Wang, Y., Zhou, K., Huang, G., Hensley, C., Huang, X., Ma, X., Zhao, T., Sumer, B. D., DeBerardinis, R. J., & Gao, J. (2014) · Nature Materials · doi:10.1038/nmat3819 · Cited by 773

Cancer active targeting by nanoparticles: a comprehensive review of literature

Bazak, R., Houri, M., El Achy, S., Kamel, S., & Refaat, T. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1767-3 · Cited by 756

Aptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology Approach

Fang, X., & Tan, W. (2010) · Accounts of Chemical Research · doi:10.1021/ar900101s · Cited by 747

Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestines

Wilson, D. S., Dalmasso, G., Wang, L., Sitaraman, S. V., Merlin, D., & Murthy, N. (2010) · Nature Materials · doi:10.1038/nmat2859 · Cited by 747

Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018892108 · Cited by 733

Matrix metalloproteinase degradation of extracellular matrix: biological consequences

Shapiro, S. D. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80035-5 · Cited by 716

Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer

Tomao, S. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s3061 · Cited by 695

Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization

Fukumura, D., & Jain, R. K. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.05.003 · Cited by 691

Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy

Huang, Y., Goel, S., Duda, D. G., Fukumura, D., & Jain, R. K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4354 · Cited by 669

Enzyme-responsive nanomaterials for controlled drug delivery

Hu, Q., Katti, P. S., & Gu, Z. (2014) · Nanoscale · doi:10.1039/c4nr04249b · Cited by 668

Matrix metalloproteinases in tumour invasion and metastasis

Curran, S., & Murray, G. I. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199911)189:3<300::aid-path456>3.0.co;2-c · Cited by 661

Current Trends in The Use of Liposomes for Tumor Targeting

Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 657

Morphological classifications of vertebrate blood capillaries

Bennett, H. S., Luft, J. H., & Hampton, J. C. (1959) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1959.196.2.381 · Cited by 635

Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles

Liu, Y., Miyoshi, H., & Nakamura, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22709 · Cited by 620

Folate receptor targeted biodegradable polymeric doxorubicin micelles

Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.003 · Cited by 620

Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances

Revia, R. A., & Zhang, M. (2016) · Materials Today · doi:10.1016/j.mattod.2015.08.022 · Cited by 612

Polymeric nanoparticles: Promising platform for drug delivery

El-Say, K. M., & El-Sawy, H. S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.052 · Cited by 608

Multi-Stimuli Sensitive Amphiphilic Block Copolymer Assemblies

Klaikherd, A., Nagamani, C., & Thayumanavan, S. (2009) · Journal of the American Chemical Society · doi:10.1021/ja809475a · Cited by 594

Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy

Pilon-Thomas, S., Kodumudi, K. N., El-Kenawi, A. E., Russell, S., Weber, A. M., Luddy, K., Damaghi, M., Wojtkowiak, J. W., Mulé, J. J., Ibrahim-Hashim, A., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1743 · Cited by 593

Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize

Fukumura, D., & Jain, R. K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21187 · Cited by 584

Tunable, Ultrasensitive pH‐Responsive Nanoparticles Targeting Specific Endocytic Organelles in Living Cells

Zhou, K., Wang, Y., Huang, X., Luby‐Phelps, K., Sumer, B. D., & Gao, J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201100884 · Cited by 573

Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases

Olson, E. S., Jiang, T., Aguilera, T. A., Nguyen, Q. T., Ellies, L. G., Scadeng, M., & Tsien, R. Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910283107 · Cited by 567

Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment

Wojtkowiak, J. W., Verduzco, D., Schramm, K. J., & Gillies, R. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200292c · Cited by 566

Carbon Dot‐Based Inorganic–Organic Nanosystem for Two‐Photon Imaging and Biosensing of pH Variation in Living Cells and Tissues

Kong, B., Zhu, A., Ding, C., Zhao, X., Li, B., & Tian, Y. (2012) · Advanced Materials · doi:10.1002/adma.201202599 · Cited by 556

Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.

Teicher, B. A., Lazo, J. S., & Sartorelli, A. C. (1981) · PubMed · Cited by 555

Pubertal Changes in Daytime Sleepiness

Mary, A. C., Harvey, K., Duke, P., Thomas, F. A., Iris, F. L., & William, C. D. (1980) · Sleep · doi:10.1093/sleep/2.4.453 · Cited by 545

Drug Release from Electric-Field-Responsive Nanoparticles

Ge, J., Neofytou, E., Cahill, T. J., Beygui, R. E., & Zare, R. N. (2012) · ACS Nano · doi:10.1021/nn203430m · Cited by 534

Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas

Cathcart, J., Pulkoski-Gross, A., & Cao, J. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2014.12.002 · Cited by 504

Type IV collagenases in tumor invasion and metastasis

Stetler-Stevenson, W. G. (1990) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00049520 · Cited by 502

Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins

Murshed, M., Schinke, T., McKee, M. D., & Karsenty, G. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200402046 · Cited by 498

Analyses of repeated failures in cancer therapy for solid tumors: Poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs

Maeda, H., & Khatami, M. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0185-6 · Cited by 491

Matrix Metalloprotease 2-Responsive Multifunctional Liposomal Nanocarrier for Enhanced Tumor Targeting

Zhu, L., Kate, P., & Torchilin, V. P. (2012) · ACS Nano · doi:10.1021/nn300524f · Cited by 489

Liposome-based drug delivery in breast cancer treatment

Park, J. W. (2002) · Breast Cancer Research · doi:10.1186/bcr432 · Cited by 469

Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy

Pradhan, P., Giri, J., Rieken, F., Koch, C., Mykhaylyk, O., Döblinger, M., Banerjee, R., Bahadur, D., & Plank, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.002 · Cited by 468

Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?

Kerbel, R. S. (2006) · Science · doi:10.1126/science.1125950 · Cited by 466

Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling

Nathan, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18174 · Cited by 456

Tumor pH-responsive flower-like micelles of poly(l-lactic acid)-b-poly(ethylene glycol)-b-poly(l-histidine)

Lee, E. S., Oh, K. T., Kim, D., Youn, Y. S., & Bae, Y. H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.006 · Cited by 446

Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin

Sun, H., Guo, B., Cheng, R., Meng, F., Liu, H., & Zhong, Z. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.051 · Cited by 438

Magnetite nanoparticles for medical MR imaging

Stephen, Z. R., Kievit, F. M., & Zhang, M. (2011) · Materials Today · doi:10.1016/s1369-7021(11)70163-8 · Cited by 432

Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues

Buck, M. R., Karustis, D. G., Day, N. A., Honn, K. V., & Sloane, B. F. (1992) · Biochemical Journal · doi:10.1042/bj2820273 · Cited by 422

Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles

Ruoslahti, E. (2012) · Advanced Materials · doi:10.1002/adma.201200454 · Cited by 419

Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes

Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., & D'Souza, G. G. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435906100 · Cited by 419

Smart drug delivery systems: from fundamentals to the clinic

Alvarez-Lorenzo, C., & Concheiro, A. (2014) · Chem. Commun. · doi:10.1039/c4cc01429d · Cited by 415

A Reactive Oxygen Species (ROS)‐Responsive Polymer for Safe, Efficient, and Targeted Gene Delivery in Cancer Cells

Shim, M. S., & Xia, Y. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209633 · Cited by 402

Acoustic behavior of microbubbles and implications for drug delivery

Kooiman, K., Vos, H. J., Versluis, M., & de Jong, N. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.003 · Cited by 401

Super pH-sensitive multifunctional polymeric micelle for tumor pHe specific TAT exposure and multidrug resistance

Lee, E. S., Gao, Z., Kim, D., Park, K., Kwon, I. C., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.024 · Cited by 400

Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery

van Dommelen, S. M., Vader, P., Lakhal, S., Kooijmans, S. A. A., van Solinge, W. W., Wood, M. J. A., & Schiffelers, R. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.021 · Cited by 398

Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs

Chen, T. S., Arslan, F., Yin, Y., Tan, S. S., Lai, R. C., Choo, A. B. H., Padmanabhan, J., Lee, C. N., de Kleijn, D. P., & Lim, S. K. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-47 · Cited by 397

Toward Photocontrolled Release Using Light-Dissociable Block Copolymer Micelles

Jiang, J., Tong, X., Morris, D., & Zhao, Y. (2006) · Macromolecules · doi:10.1021/ma060142z · Cited by 393

pH‐Triggered Thermally Responsive Polymer Core–Shell Nanoparticles for Drug Delivery

Soppimath, K. S., Tan, D. C. ‐., & Yang, Y. ‐. (2005) · Advanced Materials · doi:10.1002/adma.200401057 · Cited by 390

Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials

Caster, J. M., Patel, A. N., Zhang, T., & Wang, A. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1416 · Cited by 380

Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent

Patra, C. R., Bhattacharya, R., Wang, E., Katarya, A., Lau, J. S., Dutta, S., Muders, M., Wang, S., Buhrow, S. A., Safgren, S. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6102 · Cited by 371

Odyssey of a cancer nanoparticle: From injection site to site of action

Nichols, J. W., & Bae, Y. H. (2012) · Nano Today · doi:10.1016/j.nantod.2012.10.010 · Cited by 364

Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery

Thambi, T., Deepagan, V. G., Yoon, H. Y., Han, H. S., Kim, S.-H., Son, S., Jo, D.-G., Ahn, C.-H., Suh, Y. D., Kim, K., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.022 · Cited by 359

Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy

Denekamp, J. (1993) · The British Journal of Radiology · doi:10.1259/0007-1285-66-783-181 · Cited by 358

Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety

Zhu, L., Wang, T., Perche, F., Taigind, A., & Torchilin, V. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304987110 · Cited by 358

Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation

Johnsen, M., Lund, L. R., Rømer, J., Almholt, K., & Danø, K. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80044-6 · Cited by 356

Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

Goel, S., Wong, A. H.-K., & Jain, R. K. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006486 · Cited by 352

Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery

Tan, M. L., Choong, P. F. M., & Dass, C. R. (2010) · Peptides · doi:10.1016/j.peptides.2009.10.002 · Cited by 350

Transferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery

Bellocq, N. C., Pun, S. H., Jensen, G. S., & Davis, M. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034125f · Cited by 350

Organic electronics for precise delivery of neurotransmitters to modulate mammalian sensory function

Simon, D. T., Kurup, S., Larsson, K. C., Hori, R., Tybrandt, K., Goiny, M., Jager, E. W. H., Berggren, M., Canlon, B., & Richter-Dahlfors, A. (2009) · Nature Materials · doi:10.1038/nmat2494 · Cited by 349

Polyvalent Nucleic Acid/Mesoporous Silica Nanoparticle Conjugates: Dual Stimuli‐Responsive Vehicles for Intracellular Drug Delivery

Chen, C., Geng, J., Pu, F., Yang, X., Ren, J., & Qu, X. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201005471 · Cited by 335

Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer

Provenzano, P. P., & Hingorani, S. R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.569 · Cited by 323

P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review

Abdallah, H. M., Al-Abd, A. M., El-Dine, R. S., & El-Halawany, A. M. (2015) · Journal of Advanced Research · doi:10.1016/j.jare.2014.11.008 · Cited by 319

Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.

Man, S., Bocci, G., Francia, G., Green, S. K., Jothy, S., Hanahan, D., Böhlen, P., Hicklin, D. J., Bergers, G., & Kerbel, R. S. (2002) · PubMed · Cited by 314

Anticancer Drug Release from a Mesoporous Silica Based Nanophotocage Regulated by Either a One- or Two-Photon Process

Lin, Q., Huang, Q., Li, C., Bao, C., Liu, Z., Li, F., & Zhu, L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103415t · Cited by 308

A New Two‐Photon‐Sensitive Block Copolymer Nanocarrier

Babin, J., Pelletier, M., Lepage, M., Allard, J., Morris, D., & Zhao, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900255 · Cited by 305

Solid stress generated by spheroid growth estimated using a linear poroelasticity model☆

Roose, T., Netti, P. A., Munn, L. L., Boucher, Y., & Jain, R. K. (2003) · Microvascular Research · doi:10.1016/s0026-2862(03)00057-8 · Cited by 301

Mitochondrial gateways to cancer

Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Rigoni, A., Vacchelli, E., Michaud, M., Zischka, H., Castedo, M., & Kroemer, G. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.08.002 · Cited by 300

Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities

Belfiore, L., Saunders, D. N., Ranson, M., Thurecht, K. J., Storm, G., & Vine, K. L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.040 · Cited by 294

Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity

Koren, E., Apte, A., Jani, A., & Torchilin, V. P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.002 · Cited by 293

Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers

Li, Y., Xiao, K., Zhu, W., Deng, W., & Lam, K. S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.008 · Cited by 292

Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin

Petersen, G. H., Alzghari, S. K., Chee, W., Sankari, S. S., & La-Beck, N. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.028 · Cited by 290

Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas

Li, L., Hou, J., Liu, X., Guo, Y., Wu, Y., Zhang, L., & Yang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.019 · Cited by 289

Evolution and clinical translation of drug delivery nanomaterials

Hassan, S., Prakash, G., Bal Ozturk, A., Saghazadeh, S., Farhan Sohail, M., Seo, J., Remzi Dokmeci, M., Zhang, Y. S., & Khademhosseini, A. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.008 · Cited by 288

Tumoral acidic pH-responsive MPEG-poly(β-amino ester) polymeric micelles for cancer targeting therapy

Min, K. H., Kim, J.-H., Bae, S. M., Shin, H., Kim, M. S., Park, S., Lee, H., Park, R.-W., Kim, I.-S., Kim, K., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.024 · Cited by 287

Causes and Effects of Heterogeneous Perfusion in Tumors

Gillies, R. J., Schomack, P. A., Secomb, T. W., & Raghunand, N. (1999) · Neoplasia · doi:10.1038/sj.neo.7900037 · Cited by 283

A Thermoresponsive Bubble-Generating Liposomal System for Triggering Localized Extracellular Drug Delivery

Chen, K.-J., Liang, H.-F., Chen, H.-L., Wang, Y., Cheng, P.-Y., Liu, H.-L., Xia, Y., & Sung, H.-W. (2013) · ACS Nano · doi:10.1021/nn304474j · Cited by 279

Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)

Gaillard, P. J., Appeldoorn, C. C. M., Dorland, R., van Kregten, J., Manca, F., Vugts, D. J., Windhorst, B., van Dongen, G. A. M. S., de Vries, H. E., Maussang, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082331 · Cited by 273

Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging

Yang, F., Li, Y., Chen, Z., Zhang, Y., Wu, J., & Gu, N. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.051 · Cited by 273

Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies

Wang, T., Upponi, J. R., & Torchilin, V. P. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.013 · Cited by 268

Development of a hypoxia-responsive vector for tumor-specific gene therapy

Shibata, T., Giaccia, A. J., & Brown, J. M. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301124 · Cited by 266

Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome

Salem, A., Asselin, M.-C., Reymen, B., Jackson, A., Lambin, P., West, C. M. L., O’Connor, J. P. B., & Faivre-Finn, C. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx160 · Cited by 266

Imaging pH and metastasis

Hashim, A. I., Zhang, X., Wojtkowiak, J. W., Martinez, G. V., & Gillies, R. J. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1644 · Cited by 265

Hollow chitosan–silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy

Deng, Z., Zhen, Z., Hu, X., Wu, S., Xu, Z., & Chu, P. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.050 · Cited by 264

Review of therapeutic drug monitoring of anticancer drugs part 1 – Cytotoxics

Paci, A., Veal, G., Bardin, C., Levêque, D., Widmer, N., Beijnen, J., Astier, A., & Chatelut, E. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.04.014 · Cited by 260

Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach

Taylor, S., Spugnini, E. P., Assaraf, Y. G., Azzarito, T., Rauch, C., & Fais, S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.004 · Cited by 259

Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications

Wen, S., Li, K., Cai, H., Chen, Q., Shen, M., Huang, Y., Peng, C., Hou, W., Zhu, M., Zhang, G., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.010 · Cited by 257

Frontiers in cancer nanomedicine: directing mass transport through biological barriers

Ferrari, M. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.12.007 · Cited by 255

The Penetration of Anticancer Drugs through Tumor Tissue as a Function of Cellular Adhesion and Packing Density of Tumor Cells

Grantab, R., Sivananthan, S., & Tannock, I. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3077 · Cited by 254

Targeting ECM Disrupts Cancer Progression

Venning, F. A., Wullkopf, L., & Erler, J. T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00224 · Cited by 254

Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts

Eikenes, L., Bruland, Ø. S., Brekken, C., & Davies, C. D. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1472 · Cited by 251

Molecular Recognition of Small‐Cell Lung Cancer Cells Using Aptamers

Chen, H. W., Medley, C. D., Sefah, K., Shangguan, D., Tang, Z., Meng, L., Smith, J. E., & Tan, W. (2008) · ChemMedChem · doi:10.1002/cmdc.200800030 · Cited by 250

Exosomes are endogenous nanoparticles that can deliver biological information between cells

Sun, D., Zhuang, X., Zhang, S., Deng, Z.-B., Grizzle, W., Miller, D., & Zhang, H.-G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.002 · Cited by 250

Development of Multifunctional Nanoparticles for Targeted Drug Delivery and Noninvasive Imaging of Therapeutic Effect

Sajja, H., East, M., Mao, H., Wang, Y., Nie, S., & Yang, L. (2009) · Current Drug Discovery Technologies · doi:10.2174/157016309787581066 · Cited by 250

Multistage pH‐Responsive Liposomes for Mitochondrial‐Targeted Anticancer Drug Delivery

Mo, R., Sun, Q., Xue, J., Li, N., Li, W., Zhang, C., & Ping, Q. (2012) · Advanced Materials · doi:10.1002/adma.201201498 · Cited by 244

Liposomes as ‘smart’ pharmaceutical nanocarriers

Sawant, R. R., & Torchilin, V. P. (2010) · Soft Matter · doi:10.1039/b923535n · Cited by 243

Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy

Schleich, N., Po, C., Jacobs, D., Ucakar, B., Gallez, B., Danhier, F., & Préat, V. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.059 · Cited by 238

Oxygenation and differentiation in multicellular spheroids of human colon carcinoma.

Sutherland, R. M., Sordat, B., Bamat, J., Gabbert, H. E., Bourrat, B., & Mueller‐Klieser, W. (1986) · PubMed · Cited by 237

Hypoxia‐Targeted siRNA Delivery

Perche, F., Biswas, S., Wang, T., Zhu, L., & Torchilin, V. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308368 · Cited by 234

Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs

Fox, S. B., Gasparini, G., & Harris, A. L. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00323-5 · Cited by 230

The effect of interstitial pressure on tumor growth: Coupling with the blood and lymphatic vascular systems

Wu, M., Frieboes, H. B., McDougall, S. R., Chaplain, M. A. J., Cristini, V., & Lowengrub, J. (2013) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.11.031 · Cited by 229

Sequential Intra‐Intercellular Nanoparticle Delivery System for Deep Tumor Penetration

Ju, C., Mo, R., Xue, J., Zhang, L., Zhao, Z., Xue, L., Ping, Q., & Zhang, C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311227 · Cited by 229

Multi-responsive nanogels containing motifs of ortho ester, oligo(ethylene glycol) and disulfide linkage as carriers of hydrophobic anti-cancer drugs

Qiao, Z.-Y., Zhang, R., Du, F.-S., Liang, D.-H., & Li, Z.-C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.029 · Cited by 225

Lipid–Peptide Vesicle Nanoscale Hybrids for Triggered Drug Release by Mild Hyperthermia in Vitro and in Vivo

Al-Ahmady, Z. S., Al-Jamal, W. T., Bossche, J. V., Bui, T. T., Drake, A. F., Mason, A. J., & Kostarelos, K. (2012) · ACS Nano · doi:10.1021/nn302148p · Cited by 224

Feasibility Study of Particle-Assisted Laser Ablation of Brain Tumors in Orthotopic Canine Model

Schwartz, J. A., Shetty, A. M., Price, R. E., Stafford, R. J., Wang, J. C., Uthamanthil, R. K., Pham, K., McNichols, R. J., Coleman, C. L., & Payne, J. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2535 · Cited by 222

Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer

Liu, X., Lin, P., Perrett, I., Lin, J., Liao, Y.-P., Chang, C. H., Jiang, J., Wu, N., Donahue, T., Wainberg, Z., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92284 · Cited by 222

Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenografts

Eikenes, L., Tari, M., Tufto, I., Bruland, Ø. S., & de Lange Davies, C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602626 · Cited by 221

Electrically Actuatable Smart Nanoporous Membrane for Pulsatile Drug Release

Jeon, G., Yang, S. Y., Byun, J., & Kim, J. K. (2011) · Nano Letters · doi:10.1021/nl104329y · Cited by 218

Antisense Drug Technology: Principles, Strategies, and Applications

Szymkowski, D. E. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02123-7 · Cited by 218

MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome

Tagami, T., Foltz, W. D., Ernsting, M. J., Lee, C. M., Tannock, I. F., May, J. P., & Li, S.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.029 · Cited by 213

Tumor-Targeted Drug Delivery and MRI Contrast Enhancement by Chlorotoxin-Conjugated Iron Oxide Nanoparticles

Sun, C., Fang, C., Stephen, Z., Veiseh, O., Hansen, S., Lee, D., Ellenbogen, R. G., Olson, J., & Zhang, M. (2008) · Nanomedicine · doi:10.2217/17435889.3.4.495 · Cited by 213

Ultrasound-guided drug delivery in cancer

Mullick Chowdhury, S., Lee, T., & Willmann, J. K. (2017) · Ultrasonography · doi:10.14366/usg.17021 · Cited by 210

Multiple Micellization and Dissociation Transitions of Thermo- and Light-Sensitive Poly(ethylene oxide)-b-poly(ethoxytri(ethylene glycol) acrylate-co-o-nitrobenzyl acrylate) in Water

Jiang, X., Lavender, C. A., Woodcock, J. W., & Zhao, B. (2008) · Macromolecules · doi:10.1021/ma7028105 · Cited by 207

Selenium-containing block copolymers and their oxidation-responsive aggregates

Ma, N., Li, Y., Ren, H., Xu, H., Li, Z., & Zhang, X. (2010) · Polymer Chemistry · doi:10.1039/c0py00144a · Cited by 206

Near-infrared-light responsive nanoscale drug delivery systems for cancer treatment

Yang, G., Liu, J., Wu, Y., Feng, L., & Liu, Z. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.04.004 · Cited by 205

Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth

Guedan, S., Rojas, J. J., Gros, A., Mercade, E., Cascallo, M., & Alemany, R. (2010) · Molecular Therapy · doi:10.1038/mt.2010.79 · Cited by 204

Temozolomide Nanoparticles for Targeted Glioblastoma Therapy

Fang, C., Wang, K., Stephen, Z. R., Mu, Q., Kievit, F. M., Chiu, D. T., Press, O. W., & Zhang, M. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am5092165 · Cited by 204

Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds

Rivera Gil, P., Hühn, D., del Mercato, L. L., Sasse, D., & Parak, W. J. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.009 · Cited by 202

Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review

Al-Abd, A. M., Alamoudi, A. J., Abdel-Naim, A. B., Neamatallah, T. A., & Ashour, O. M. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.06.006 · Cited by 198

An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability

Pang, H.-B., Braun, G. B., Friman, T., Aza-Blanc, P., Ruidiaz, M. E., Sugahara, K. N., Teesalu, T., & Ruoslahti, E. (2014) · Nature Communications · doi:10.1038/ncomms5904 · Cited by 195

Angiogenic factors as potential drug target: Efficacy and limitations of anti-angiogenic therapy

Gacche, R. N., & Meshram, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.05.002 · Cited by 193

Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro

Yu, C., Hu, Y., Duan, J., Yuan, W., Wang, C., Xu, H., & Yang, X.-D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024077 · Cited by 190

Pathophysiological Basis for the Formation of the Tumor Microenvironment

Horsman, M. R., & Vaupel, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00066 · Cited by 189

Molecular determinants of endothelial transcytosis and their role in endothelial permeability

Predescu, S. A., Predescu, D. N., & Malik, A. B. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00436.2006 · Cited by 188

Smart nanoparticles for drug delivery: Boundaries and opportunities

Lee, B. K., Yun, Y. H., & Park, K. (2015) · Chemical Engineering Science · doi:10.1016/j.ces.2014.06.042 · Cited by 187

Lessons From Anti–Vascular Endothelial Growth Factor and Anti–Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma

Lu-Emerson, C., Duda, D. G., Emblem, K. E., Taylor, J. W., Gerstner, E. R., Loeffler, J. S., Batchelor, T. T., & Jain, R. K. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9575 · Cited by 179

Strategies to Increase Drug Penetration in Solid Tumors

Choi, I.-K., Strauss, R., Richter, M., Yun, C.-O., & Lieber, A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00193 · Cited by 178

Poly(PS-b-DMA) micelles for reactive oxygen species triggered drug release

Gupta, M. K., Meyer, T. A., Nelson, C. E., & Duvall, C. L. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.042 · Cited by 171

The Solid Mechanics of Cancer and Strategies for Improved Therapy

Stylianopoulos, T. (2017) · Journal of Biomechanical Engineering · doi:10.1115/1.4034991 · Cited by 169

Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: Swelling induced physical disruption of endosome by cold shock

Lee, S. H., Choi, S. H., Kim, S. H., & Park, T. G. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.011 · Cited by 166

Image-Guided Breast Tumor Therapy Using a Small Interfering RNA Nanodrug

Kumar, M., Yigit, M., Dai, G., Moore, A., & Medarova, Z. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2070 · Cited by 164

Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil

Subudhi, M., Jain, A., Jain, A., Hurkat, P., Shilpi, S., Gulbake, A., & Jain, S. (2015) · Materials · doi:10.3390/ma8030832 · Cited by 164

pH and Redox Dual Responsive Nanoparticle for Nuclear Targeted Drug Delivery

K. C., R. B., Thapa, B., & Xu, P. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300274g · Cited by 162

Targeting Anti—Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion

Gosk, S., Vermehren, C., Storm, G., & Moos, T. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000135592.28823.47 · Cited by 160

Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting

Rahim, M. A., Jan, N., Khan, S., Shah, H., Madni, A., Khan, A., Jabar, A., Khan, S., Elhissi, A., Hussain, Z., et al. (2021) · Cancers · doi:10.3390/cancers13040670 · Cited by 323

Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation

Li, J., & Kataoka, K. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09029 · Cited by 281

Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy

Zhan, Q., Yi, K., Qi, H., Li, S., Li, X., Wang, Q., Wang, Y., Liu, C., Qiu, M., Yuan, X., et al. (2020) · Theranostics · doi:10.7150/thno.45028 · Cited by 168

Tumor‐Specific Photothermal‐Therapy‐Assisted Immunomodulation via Multiresponsive Adjuvant Nanoparticles

Liu, T., Zhu, M., Chang, X., Tang, X., Yuan, P., Tian, R., Zhu, Z., Zhang, Y., & Chen, X. (2023) · Advanced Materials · doi:10.1002/adma.202300086 · Cited by 98

Size Changeable Nanomedicines Assembled by Noncovalent Interactions of Responsive Small Molecules for Enhancing Tumor Therapy

Ma, X., Chen, X., Yi, Z., Deng, Z., Su, W., Chen, G., Ma, L., Ran, Y., Tong, Q., & Li, X. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c04698 · Cited by 36